Renal handling of CS-023 (RO4908463), a novel parenteral carbapenem antibiotic, in rabbits in comparison with meropenem

Xenobiotica

Volumn 36, Issue 12, 2006, Pages 1273-1287

  Shibayama, T ^a   Yamamura, N ^a   Matsushita, Y ^a   Tokui, T ^a   Hirota, T ^a   Ikeda, T ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

Carbapenem antibiotic; CS 023 (RO4908463); Rabbit; Renal handling

Indexed keywords

4 AMINOHIPPURIC ACID; CARBAPENEM DERIVATIVE; CS 023; MEROPENEM; PROBENECID; RO 4908463;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BOLUS INJECTION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EXCRETION; DRUG HALF LIFE; DRUG UPTAKE; DRUG URINE LEVEL; GLOMERULUS FILTRATION RATE; KIDNEY CLEARANCE; KIDNEY CORTEX; KIDNEY TUBULE EXCRETION; MALE; NONHUMAN; RABBIT;

ANIMALS; CARBAPENEMS; KIDNEY; KIDNEY CORTEX; KIDNEY TUBULES; MALE; METABOLIC CLEARANCE RATE; MICROSOMES; MODELS, ANIMAL; RABBITS; THIENAMYCINS;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 33845662120     PISSN: 00498254     EISSN: 13665928     Source Type: Journal    
DOI: 10.1080/00498250600944326     Document Type: Article

References (36)

1. Arita T, Hori R, Owada E, Takahashi K. 1969. Transformation and excretion of drugs in biological systems. I. Renal excretion mechanisms of sulfonamides. Chemical and Pharmaceutical Bulletin 17:2526-2532.
2. Bahn A, Knabe M, Hagos Y, Rodiger M, Godehardt S, Neufeld DS, Evans KK, Burckhardt G, Wright SH. 2002. Interaction of the metal chelator 2,3-dimercapto-1-propanesulfonate with rabbit multispecific organic transporter 1 (rbOAT1). Molecular Pharmacology 62:1128-1136.
3. Bax RP, Bastain W, Featherstone A, Wilkinson DM, Hutchison M, Haworth SJ. 1989. The pharmacokinetics of meropenem in volunteers. Journal of Antimicrobial Chemotherapy 24(Suppl. A):311-320.
4. Birnbaum J, Kahan FM, Kropp H, MacDonald JS. 1985. Carbapenems, a new class of beta-lactam antibiotics. Discovery and development of imipenem/cilastatin. American Journal of Medicine 78(Suppl. 6A):3-21.
5. Bonfiglio G, Russo G, Nicoletti G. 2002. Recent developments in carbapenems. Expert Opinion on Investigational Drugs 11:529-544.
6. Brown GR. 1993. Cephalosporin-probenecid drug interactions. Clinical Pharmacokinetics 24:289-300.
7. Burckhardt BC, Burckhardt G. 2003. Transport of organic anions across the basolateral membrane of proximal tubule cells. Reviews of Physiology, Biochemistry and Pharmacology 146:95-158.
8. Burman LA, Nilsson-Ehle I, Hutchison M, Haworth SJ, Norrby SR. 1991. Pharmacokinetics of meropenem and its metabolite ICI213,689 in healthy subjects with known renal metabolism of imipenem. Journal of Antimicrobial Chemotherapy 27:219-224.
9. Craig WA. 1997. The pharmacology of meropenem, a new carbapenem antibiotic. Clinical Infectious Diseases 24(Suppl. 2):S266-S275.
10. Craig WA. 1998. Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men. Clinical Infectious Diseases 26:1-10.
11. Davies B, Morris T. 1993. Physiological parameters in laboratory animals and humans. Pharmaceutical Research 10:1093-1095.
12. Dische Z, Borenfreund E. 1951. A new spectrophotometric method for the detection and determination of keto sugars and trioses. Journal of Biological Chemistry 192:583-587.
13. Drusano GL. 1986. An overview of the pharmacology of imipenem/cilastatin. Journal of Antimicrobial Chemotherapy 18(Suppl. E):79-92.
14. Drusano GL. 2003. Prevention of resistance: A goal for dose selection for antimicrobial agents. Clinical Infectious Diseases 36(Suppl. 1):S42-S50.
15. Drusano GL, Standiford HC. 1985. Pharmacokinetic profile of imipenem/colastatin in normal volunteers. American Journal of Medicine 78(Suppl. 6A):47-53.
16. Inui K, Masuda S, Saito H. 2000. Cellular and molecular aspects of drug transport in the kidney. Kidney International 58:944-958.
17. Kamiya A, Okumura K, Hori R. 1983. Quantitative investigation on renal handling of drugs in rabbits, dogs, and humans. Journal of Pharmaceutical Sciences 72:440-443.
18. Kawamoto I. 1998. 1β-Methylcarbapenem antibiotics. Drugs Future 23:181-189.
19. Kawamoto I, Shimoji Y, Kanno O, Kojima K, Ishikawa K, Matsuyama E, Ashida Y, Shibayama T, Fukuoka T, Ohya S. 2003. Synthesis and structure-activity relationships of novel parenteral carbapenems, CS-023 (R-115685) and related compounds containing an amidine moiety. Journal of Antibiotics 56:565-579.
20. Koga T, Abe T, Inoue H, Takenouchi T, Kitayama A, Yoshida T, Masuda N, Sugihara C, Kakuta M, Nakagawa M, Shibayama T, Matsushita Y, Hirota T, Ohya S, Utsui Y, Fukuoka T, Kuwahara S. 2005. In vitro and in vivo antibacterial activities of CS-023 (RO4908463), a novel parenteral carbapenem. Antimicrobial Agents and Chemotherapy 49:3239-3250.
21. Motohashi H, Sakurai Y, Saito H, Masuda S, Urakami Y, Goto M, Fukatsu A, Ogawa A, Inui K. 2002. Gene expression levels and immunolocalization of organic ion transporters in the human kidney. Journal of the American Society of Nephrology 13:866-874.
22. Murer H, Hernando N, Forster I, Biber J. 2000. Proximal tubular phosphate reabsorption: Molecular mechanisms. Physiological Reviews 80:1373-1409.
23. Naganuma H, Hirouchi Y, Kawahara Y, Inui K, Tanigawara Y, Yasuhara M, Hori R, Kuwahara S. 1991. Nephroprotective effect and its mechanism of betamipron (2) Relationships of renal excretion. Chemotherapy (Tokyo) 39(Suppl. 3):178-189.
24. Rennecke JT, Hirota T, Shibayama T, Matsushita Y, Kuwahara S, Puchler K, Ruhland A, Drewelow B. 2002. Safety, tolerability, and pharmacokinetics (PK) of CS-023, a new parenteral carbapenem, in healthy male volunteers. In: 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, 27-30 September 2002, San Diego, CA, USA. Washington, DC: American Society for Microbiology. p. F-327.
25. Schaub TP, Kartenbeck J, Konig J, Spring H, Dorsam J, Staehler G, Storkel S, Thon WF, Keppler D. 1999. Expression of the MRP2 gene-encoded conjugate export pump in human kidney proximal tubules and in renal cell carcinoma. Journal of the American Society of Nephrology 10:1159-1169.
26. Shibayama T, Matsushita Y, Kikuchi N, Kawai K, Hirota T, Kuwahara S. 2000. R-115685, a novel parenteral Carbapenem: Pharmacokinetics and metabolism in laboratory animals. In: 40th Interscience Conference on Antibacterial Agents and Chemotherapy, 17-20 September 2000, Toronto, Canada. Washington, DC: American Society for Microbiology. p. F-1233.
27. Sumita Y, Nouda H, Toda E, Kohzuki T, Kato M, Okuda T, Fukasawa M. 1992. Pharmacokinetics of meropenem, a new carbapenem antibiotic, parenterally administered to laboratory animals. Chemotherapy (Tokyo) 40(Suppl. 1):S123-S130.
28. Takahagi H, Hirota T, Matsushita Y, Muramatsu S, Tanaka M, Matsuo E. 1991. In vitro dehydropeptidase-I activity and its hydrolytic activity of panipenem in several tissues in animal species and their influence on the disposition of panipenem in vivo. Chemotherapy (Tokyo) 39(Suppl. 3):236-241.
29. Takeda M, Babu E, Narikawa S, Endou H. 2002a. Interaction of human organic transporters with various cephalosporin antibiotics. European Journal of Pharmacology 438:137-142.
30. Takeda M, Khamdang S, Narikawa S, Kimura H, Hosoyamada M, Cha SH, Sekine T, Endou H. 2002b. Characterization of methotrexate transport and its drug interactions with human organic anion transporters. Journal of Pharmacology and Experimental Therapeutics 302:666-671.
31. Takeda M, Narikawa S, Hosoyamada M, Cha SH, Sekine T, Endou H. 2001. Characterization of organic anion transport inhibitors using cells stably expressing human organic anion transporters. European Journal of Pharmacology 419:113-120.
32. Thomson KS, Moland ES. 2004. CS-023 (R-115685), a novel carbapenem with enhanced in vitro activity against oxacillin-resistant staphylococci and Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 54:557-562.
33. Ueo H, Motohashi H, Katsura T, Inui K. 2005. Human organic transporter hOAT3 is a potent transporter of cephalosporin antibiotics, in comparison with hOAT1. Biochemical Pharmacology 70:1104-1113.
34. Wong SL, Hedaya MA, Sawchuk RJ. 1992. Competitive inhibition of zidovudine clearance by probenecid during continuous coadministration. Pharmaceutical Research 9:228-235.
35. Wright SH, Dantzler WH. 2003. Molecular and cellular physiology of renal organic cation and anion transport. Physiological Reviews 84:987-1049.
36. Zhang X, Groves CE, Bahn A, Barendt WM, Prado MD, Rodiger M, Chatsudthipong V, Burckhardt G, Wright SH. 2004. Relative contribution of OAT and OCT transporters to organic electrolyte transport in rabbit proximal tubule. American Journal of Physiology. Renal Physiology 287:F999-F1010.